Certara’s Dr. Fran Brown, Senior Vice President of Drug Development Science, is quoted in this WIRED article about the FDA’s recent rejection of Lykos Therapeutics’ proposed MDMA treatment for post-traumatic stress disorder. Read the article for her insights into the challenges of designing clinical trials to assess the therapeutic potential of psychedelics.
2024 年 8 月 26 日
